Published in J Biol Chem on May 05, 1992
Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils. J Exp Med (1996) 3.33
Relationship between colonial morphology and adherence of Streptococcus pneumoniae. Infect Immun (1995) 2.50
Platelet-activating factor: receptors and signal transduction. Biochem J (1993) 2.12
Impaired anaphylactic responses with intact sensitivity to endotoxin in mice lacking a platelet-activating factor receptor. J Exp Med (1998) 1.98
Common and distinct intracellular signaling pathways in human neutrophils utilized by platelet activating factor and FMLP. J Clin Invest (1997) 1.66
Molecular Architecture of G Protein-Coupled Receptors. Drug Dev Res (1996) 1.39
Two cystic fibrosis transmembrane conductance regulator mutations have different effects on both pulmonary phenotype and regulation of outwardly rectified chloride currents. Proc Natl Acad Sci U S A (1995) 1.13
Tyrosine phosphorylation and activation of a new mitogen-activated protein (MAP)-kinase cascade in human neutrophils stimulated with various agonists. Biochem J (1996) 1.09
Effect of lipopolysaccharide on mitogen-activated protein kinases and cytosolic phospholipase A2. Biochem J (1995) 1.07
Platelet-activating factor mediates acid-induced lung injury in genetically engineered mice. J Clin Invest (1999) 1.06
Traumatic brain injury-associated coagulopathy. J Neurotrauma (2012) 0.93
A murine platelet-activating factor receptor gene: cloning, chromosomal localization and up-regulation of expression by lipopolysaccharide in peritoneal resident macrophages. Biochem J (1996) 0.89
N-terminally tagged prion protein supports prion propagation in transgenic mice. Protein Sci (1997) 0.85
Agonist-induced down-regulation of platelet-activating factor receptor gene expression in U937 cells. Biochem J (1994) 0.79
Identification and functional characterization of platelet-activating factor receptors in human leukocyte populations using polyclonal anti-peptide antibody. Proc Natl Acad Sci U S A (1993) 0.78
Prolonged activation of phospholipase D in Chinese hamster ovary cells expressing platelet-activating-factor receptor lacking cytoplasmic C-terminal tail. Biochem J (1997) 0.77
New nucleotide sequence data on the EMBL File Server. Nucleic Acids Res (1992) 0.75
Metabolomics analysis and modeling suggest a lysophosphocholines-PAF receptor interaction in fibromyalgia. PLoS One (2014) 0.75
The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell (1996) 17.13
CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5. Nature (1996) 11.37
Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell (1998) 7.46
Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice. J Exp Med (1998) 6.52
Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor. Nature (1995) 5.15
Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry. Cell (1999) 4.97
Metabolic regulation of brain Abeta by neprilysin. Science (2001) 4.47
Requirement of the chemokine receptor CXCR3 for acute allograft rejection. J Exp Med (2000) 3.84
The C5a chemoattractant receptor mediates mucosal defence to infection. Nature (1996) 3.73
Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils. J Exp Med (1996) 3.33
Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis. J Exp Med (1999) 3.23
The chemotactic receptor for human C5a anaphylatoxin. Nature (1991) 3.15
Two orphan seven-transmembrane segment receptors which are expressed in CD4-positive cells support simian immunodeficiency virus infection. J Exp Med (1997) 2.75
Expression and biologic characterization of the murine chemokine KC. J Immunol (1995) 2.66
Pulmonary responses to bronchoconstrictor agonists in the mouse. J Appl Physiol (1985) (1988) 2.64
C5A anaphylatoxin and its seven transmembrane-segment receptor. Annu Rev Immunol (1994) 2.57
HIV-1 entry and macrophage inflammatory protein-1beta-mediated signaling are independent functions of the chemokine receptor CCR5. J Biol Chem (1997) 2.55
Constitutive and inducible nitric oxide synthase gene expression, regulation, and activity in human lung epithelial cells. Proc Natl Acad Sci U S A (1994) 2.41
A tyrosine-rich region in the N terminus of CCR5 is important for human immunodeficiency virus type 1 entry and mediates an association between gp120 and CCR5. J Virol (1998) 2.28
A role for the C3a anaphylatoxin receptor in the effector phase of asthma. Nature (2000) 2.24
Neurogenic amplification of immune complex inflammation. Science (1996) 2.05
Utilization of C-C chemokine receptor 5 by the envelope glycoproteins of a pathogenic simian immunodeficiency virus, SIVmac239. J Virol (1997) 2.04
CD4-independent binding of SIV gp120 to rhesus CCR5. Science (1997) 1.87
Lymph node trafficking and antigen presentation by endobronchial eosinophils. J Clin Invest (2000) 1.85
Impaired inflammatory responses in the reverse arthus reaction through genetic deletion of the C5a receptor. J Exp Med (1997) 1.83
A tyrosine-sulfated peptide based on the N terminus of CCR5 interacts with a CD4-enhanced epitope of the HIV-1 gp120 envelope glycoprotein and inhibits HIV-1 entry. J Biol Chem (2000) 1.80
The murine interleukin 8 type B receptor homologue and its ligands. Expression and biological characterization. J Biol Chem (1994) 1.72
Isolation of three separate anaphylatoxins from complement-activated human serum. Mol Cell Biochem (1981) 1.70
The orphan seven-transmembrane receptor apj supports the entry of primary T-cell-line-tropic and dualtropic human immunodeficiency virus type 1. J Virol (1998) 1.63
AIDS vaccine development. Science (1998) 1.62
The envelope glycoprotein ectodomains determine the efficiency of CD4+ T lymphocyte depletion in simian-human immunodeficiency virus-infected macaques. J Exp Med (1998) 1.59
Cloning, sequencing and expression of the human thyrotropin (TSH) receptor: evidence for binding of autoantibodies. Biochem Biophys Res Commun (1989) 1.57
Early local generation of C5a initiates the elicitation of contact sensitivity by leading to early T cell recruitment. J Immunol (2000) 1.57
Neurokinin-1 (NK-1) receptor is required in Clostridium difficile- induced enteritis. J Clin Invest (1998) 1.57
Neutral endopeptidase modulation of septic shock. J Exp Med (1995) 1.53
Targeted disruption of the beta-chemokine receptor CCR1 protects against pancreatitis-associated lung injury. J Clin Invest (1997) 1.51
Characterization of a receptor for C5a anaphylatoxin on human eosinophils. J Biol Chem (1989) 1.49
Evidence for a direct negative coupling between dopamine-D2 receptors and PLC by heterotrimeric Gi1/2 proteins in rat anterior pituitary cell membranes. Endocrinology (2002) 1.48
The pro-inflammatory seven-transmembrane segment receptors of the leukocyte. Curr Opin Immunol (1994) 1.47
Role of protein kinases in stimulation of human polymorphonuclear leukocyte oxidative metabolism by various agonists. Differential effects of a novel protein kinase inhibitor. J Clin Invest (1986) 1.44
Mapping of genes for the human C5a receptor (C5AR), human FMLP receptor (FPR), and two FMLP receptor homologue orphan receptors (FPRH1, FPRH2) to chromosome 19. Genomics (1992) 1.42
Cleavage of tryptophanyl peptide bonds in cytochrome b5 by cyanogen bromide. J Biol Chem (1977) 1.38
A serine esterase released by human alveolar macrophages is closely related to liver microsomal carboxylesterases. J Biol Chem (1991) 1.38
Evaluation of a humidified nasal high-flow oxygen system, using oxygraphy, capnography and measurement of upper airway pressures. Anaesth Intensive Care (2011) 1.33
Proteolytic cleavage of horse liver cytochrome b5. Primary structure of the heme-containing moiety. J Biol Chem (1976) 1.33
The control of microvascular permeability and blood pressure by neutral endopeptidase. Nat Med (1997) 1.31
The amino acid sequence specificity of a protease from spores of Bacillus megaterium. J Biol Chem (1980) 1.28
Stable expression of the human TSH receptor in CHO cells and characterization of differentially expressing clones. Biochem Biophys Res Commun (1990) 1.27
Molecular characterization of two murine eosinophil beta chemokine receptors. J Immunol (1995) 1.26
Specific interactions of chemoattractant factor receptors with G-proteins. J Biol Chem (1993) 1.25
Identification of classical anaphylatoxin as the des-Arg form of the C5a molecule: evidence of a modulator role for the oligosaccharide unit in human des-Arg74-C5a. Proc Natl Acad Sci U S A (1981) 1.23
Neutral endopeptidase (EC 3.4.24.11) terminates colitis by degrading substance P. Proc Natl Acad Sci U S A (1999) 1.22
Receptor class desensitization of leukocyte chemoattractant receptors. Proc Natl Acad Sci U S A (1991) 1.22
Differential expression and cross-regulatory function of RANTES during mycobacterial (type 1) and schistosomal (type 2) antigen-elicited granulomatous inflammation. J Immunol (1999) 1.21
Structure and function of the murine chemokine receptor CXCR3. Eur J Immunol (1999) 1.18
Anaphylatoxin from the fifth component of porcine complement. Purification and partial chemical characterization. J Biol Chem (1979) 1.17
Priming of the respiratory burst of neutrophils by diacylglycerol. Independence from activation or translocation of protein kinase C. J Biol Chem (1987) 1.17
Peptidase modulation of the pulmonary effects of tachykinins in tracheal superfused guinea pig lungs. J Clin Invest (1990) 1.15
Protective effects of neurokinin-1 receptor during colitis in mice: role of the epidermal growth factor receptor. Br J Pharmacol (2002) 1.14
Cloning and chromosomal mapping of an orphan chemokine receptor: mouse RDC1. Immunogenetics (1998) 1.13
Purification of glycoproteins. Methods Enzymol (1990) 1.12
Substance P and bradykinin stimulate plasma extravasation in the mouse gastrointestinal tract and pancreas. Am J Physiol (1997) 1.11
Response of human neutrophils to C5a: a role for the oligosaccharide moiety of human C5ades Arg-74 but not of C5a in biologic activity. J Immunol (1981) 1.10
Covalent structure of the membranous segment of horse cytochrome b5. Chemical cleavage of the native hemoprotein. J Biol Chem (1977) 1.08
The human neurokinin A (substance K) receptor. Molecular cloning of the gene, chromosome localization, and isolation of cDNA from tracheal and gastric tissues. J Biol Chem (1990) 1.08
Human substance P receptor (NK-1): organization of the gene, chromosome localization, and functional expression of cDNA clones. Biochemistry (1991) 1.06
Primary structure of the membranous segment of cytochrome b5. Proc Natl Acad Sci U S A (1977) 1.04
PAf receptor anchors Streptococcus pneumoniae to activated human endothelial cells. Adv Exp Med Biol (1996) 1.04
Chemokine receptor 1 knockout abrogates natural killer cell recruitment and impairs type-1 cytokines in lymphoid tissue during pulmonary granuloma formation. Am J Pathol (2000) 1.04
Complement factor C5a exerts an anti-inflammatory effect in acute pancreatitis and associated lung injury. Am J Physiol Gastrointest Liver Physiol (2001) 1.03
Sulfated tyrosines contribute to the formation of the C5a docking site of the human C5a anaphylatoxin receptor. J Exp Med (2001) 1.02
Cutting edge: identification of the orphan receptor G-protein-coupled receptor 2 as CCR10, a specific receptor for the chemokine ESkine. J Immunol (2000) 1.02
Expression of C5a receptor in mouse brain: role in signal transduction and neurodegeneration. Neuroscience (1999) 1.00
Human chemotaxis receptor genes cluster at 19q13.3-13.4. Characterization of the human C5a receptor gene. Biochemistry (1993) 1.00
Substance P mediates inflammatory oedema in acute pancreatitis via activation of the neurokinin-1 receptor in rats and mice. Br J Pharmacol (2000) 0.98